News | September 19, 2025
Roche secures CE mark for Accu-Chek SmartGuide CGM with mySugr app integration
This predictive technology empowers people with diabetes to take preventive action before complications arise
This predictive technology empowers people with diabetes to take preventive action before complications arise
The Phase Ib MAD study is a randomized, double-blind, placebo-controlled trial conducted in the United States
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
The survey revealed that the proportion of individuals experiencing constant thoughts about food throughout the day declined by 46 percent after starting Wegovy
Cagrilintide represents a novel approach to obesity management
Subscribe To Our Newsletter & Stay Updated
